MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2026.1822890

Медицинская библиотека · Frontiers in pharmacology · 2026

Baicalin-geniposide attenuates pulmonary inflammation and vascular injury via HMGB1 blockade: insights from a cerebral ischemia-reperfusion model and implications for pulmonary hypertension.

Gao Leying, Wu Qianqian, Li Xiaoqiu, Long Yu, Li Nan

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Pulmonary complications following stroke are a leading cause of death, with no targeted therapies available. Inflammation drives both post-stroke neurological damage and secondary acute lung injury (CIS-ALI). High mobility group box 1 (HMGB1), a key mediator in cerebral ischemia stroke (CIS), translocates from the nucleus to cytoplasm and is released extracellularly, triggering inflammatory cascades. The combination of two bioactive metabolites, baicalin and geniposide (BG), exhibits anti-inflammatory and neuroprotective properties, but its efficacy against CIS-ALI remains unexplored. This study investigated BG's mechanisms using in vitro and in vivo models.

METHODS

This study investigated the mechanisms of BG using in vitro and in vivo models. In vitro, LPS-stimulated BV2 microglia and RAW264.7 macrophages were co-cultured. In vivo, a rat model of middle cerebral artery occlusion/reperfusion (MCAO/R) was used. BG was administered at doses of 25-50 mg/kg in rats.

RESULTS

BG dose-dependently suppressed pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and nitric oxide (NO), while attenuating HMGB1 nucleocytoplasmic translocation via JAK2/STAT3 inhibition. BG (25-50 mg/kg) reduced cerebral infarct volume, neurological deficits, and lung edema. Mechanistically, BG blocked HMGB1 nuclear export in ischemic brains, thereby decreasing HMGB1 levels in serum and lungs, and disrupting inflammatory cross-talk.

DISCUSSION: These findings highlight BG's unique capacity to concurrently mitigate cerebral injury and secondary ALI by targeting the JAK2/STAT3 axis, offering a safe, multi-targeted strategy against CIS-related complications. Given the shared pathological features between ALI and PH-including inflammation, vascular hyperpermeability, and JAK2/STAT3-driven injury cascades-these findings provide a mechanistic rationale for exploring BG as a potential therapeutic candidate for pulmonary hypertension and related pulmonary vascular diseases.

Для цитирования: Gao Leying, Wu Qianqian, Li Xiaoqiu, Long Yu, Li Nan. Baicalin-geniposide attenuates pulmonary inflammation and vascular injury via HMGB1 blockade: insights from a cerebral ischemia-reperfusion model and implications for pulmonary hypertension.. Frontiers in pharmacology. 2026. DOI: 10.3389/fphar.2026.1822890.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.